Nabriva Therapeutics Us, Inc

XENLETA

View Prices
  1. Home
    2.  / 
  2. J Code
    3.  / XENLETA – J0691

Manufacturer:

Nabriva Therapeutics Us, Inc

Name:

XENLETA

HCPCS Code Descriptor:

Injection, lefamulin, 1 mg

Category:

J Code

HCPCS:

J0691

NDC(s):

72000-0120-06

Primary Type:

Antibiotic

Generic Status:

Single-Source

Route of Administration:

Intravenous

About:

XENLETA is an Antibiotic drug manufactured by Nabriva Therapeutics Us, Inc and administered via the Intravenous route of administration. The J Code: J0691 is aligned to the drug XENLETA.

View Prices

Access Pricing and More By Registering

Register Now

HCPCS Added Date:

7/1/20

HCPCS Effective Date:

1/1/23

HCPCS Short Description:

Inj lefamulin 1 mg

Billing and Coding Guide:

https://www.xenleta.com/pdf/xenleta-billing-and-coding-guide.pdf

Patient Assistance:

https://www.xenleta.com/access-support